This Top-Dollar Drug Hits the Discount Rack

Filed under: drug treatment news articles

Zaltrap, a joint project from Sanofi and Regeneron (Nasdaq: REGN ) , received approval from the Food and Drug Administration in August for treating patients with advanced colorectal cancer. Trials showed that Zaltrap barely extended patient lifespan by …
Read more on Motley Fool

Is It Time To Look At Keryx Again?

Filed under: drug treatment news articles

A lot is riding on Keryx's Phase III clinical trial that is determining if Zerenex is a viable treatment for elevated phosphate levels (hyperphosphatemia) in patients with end-stage renal disease (ESRD). The study is being … In other words, the …
Read more on Seeking Alpha

Alnylam: No Approved Drugs, No Promising Candidates, No Justification For …

Filed under: drug treatment news articles

This is an important thing to note, as Alnylam has made lots of promotional hay out of its Phase I trials, where it is able to show strong results when treating healthy patients with its drug candidates. This brings us to the second error that has led …
Read more on Seeking Alpha